Mono-Methyl-Histone H3 (K80) Antibody

Basic Research Questions

• What is Mono-Methyl-Histone H3 (K80) Antibody and what is its specificity?

  Mono-Methyl-Histone H3 (K80) Antibody is a polyclonal antibody that specifically recognizes histone H3 proteins only when mono-methylated at lysine 80. These antibodies are typically raised in rabbits using synthesized peptides derived from the region surrounding the K80 methylation site of human histone H3 . The specificity is a critical characteristic of this antibody, as it does not cross-react with non-methylated, di-methylated, or tri-methylated forms of H3K80, nor with other methylated residues on histone H3 .

  The antibody's specificity is achieved through affinity purification from rabbit antiserum using epitope-specific immunogen chromatography . When validating antibody specificity, researchers should conduct peptide competition assays and use genetic models where the K80 methylation machinery has been altered as controls.

• What are the recommended applications and dilutions for Mono-Methyl-Histone H3 (K80) Antibody?

  The Mono-Methyl-Histone H3 (K80) Antibody is validated for the following applications with corresponding recommended dilutions:

  Application	Dilution Range	Notes
  Western Blotting (WB)	1:500-1:2000	For detecting denatured protein samples
  ELISA	1:10000-1:20000	For high-sensitivity detection

  These antibodies typically react with human, mouse, and rat samples . For optimal results in Western blotting, researchers should use histone acid extraction protocols to enrich for histones before analysis, as described in published methods using 0.4M HCl for nuclear extraction .

• How do you properly prepare and extract histones for detection with Mono-Methyl-Histone H3 (K80) Antibody?

  Proper histone extraction is crucial for successful detection of H3K80 mono-methylation. A recommended acid extraction protocol is as follows:

  1. Collect approximately 2 × 10^8 cells and wash three times with appropriate buffer (e.g., KK2 or PBS)

  2. Lyse cells using AE lysis buffer (50 mM Tris pH 8.0, 20 mM NaCl, 3 mM MgCl₂, 3 mM CaCl₂, 0.5 M Sorbitol, 0.6% Triton X-100, 10 mM Sodium butyrate)

  3. Supplement with phosphatase inhibitors and protease inhibitor cocktail

  4. Collect nuclei by centrifugation at 2500 × g at 4°C

  5. Wash nuclei twice with AE wash buffer (lysis buffer without salts and supplemented with 100 mM β-mercaptoethanol)

  6. Extract histones using 250 μl 0.4M HCl for 1 hour at 4°C

  7. Neutralize with appropriate buffer before proceeding with SDS-PAGE

  This method ensures enrichment of histones and removal of potential contaminants that could interfere with antibody binding.

• What controls should be included when using Mono-Methyl-Histone H3 (K80) Antibody?

  Proper experimental controls are essential when working with histone modification antibodies:

  • Positive control: Use cell lines known to express high levels of H3K80me1, such as HCT116 cells that have been characterized for this modification

  • Negative control: Include samples treated with demethylase enzymes or from cells where the relevant methyltransferase has been knocked down

  • Peptide competition: Pre-incubate the antibody with synthetic H3K80me1 peptides to confirm binding specificity

  • Cross-reactivity control: Test against related modifications like H3K79me1 or H3K4me1 to ensure specificity

  • Loading control: Include an antibody against total histone H3 to normalize for histone content

  These controls help validate antibody specificity and ensure reliable interpretation of results in epigenetic studies.

Advanced Research Questions

• How does mono-methylation at K80 on histone H3 differ functionally from other methylation sites on histone H3?

  Histone H3 contains multiple lysine residues that can be methylated, including K4, K9, K27, K36, K79, and K80. Each methylation site serves distinct functions in chromatin regulation:

  Methylation Site	Primary Function	Associated Complexes	Chromatin State
  H3K4me1	Enhancer marking	BPTF, ING2 (PHD fingers)	Active/Poised
  H3K9me1	Transcriptional repression	HP1 (chromodomain)	Repressive
  H3K27me1	Transcriptional repression	PRC1 complexes	Repressive
  H3K36me1	Transcription elongation	-	Active
  H3K79me1	DNA damage response	53BP1 (tudor domain)	Variable
  H3K80me1	Unclear, likely regulatory	-	Under investigation

  Unlike well-characterized sites such as H3K4 (associated with enhancers when mono-methylated) or H3K9 (associated with heterochromatin), the specific function of H3K80 mono-methylation is still being investigated . Current research suggests it may interact with other modifications, potentially forming part of a "histone code" that regulates chromatin structure and accessibility .

  Methodologically, researchers can use techniques like ChIP-seq with the Mono-Methyl-Histone H3 (K80) Antibody followed by correlation with gene expression data (RNA-seq) to identify functional associations of this mark with transcriptional states.

• What are the technical considerations for ChIP-seq experiments using Mono-Methyl-Histone H3 (K80) Antibody?

  For successful ChIP-seq experiments targeting H3K80me1, consider the following technical aspects:

  1. Crosslinking optimization: Standard 1% formaldehyde for 10 minutes at room temperature works for most histone modifications, but optimization may be required for H3K80me1

  2. Sonication conditions: Aim for chromatin fragments of 200-300bp for optimal resolution

  3. Antibody amounts: Use approximately 10 μg of chromatin with 5-10 μg of antibody per immunoprecipitation

  4. Beads selection: Protein A/G magnetic beads generally perform well with rabbit polyclonal antibodies

  5. Controls: Include input chromatin, IgG control, and spike-in normalization controls

  6. Washing stringency: Optimize salt concentration in wash buffers to reduce background while maintaining specific signal

  7. Library preparation considerations: Account for GC bias and use appropriate adapter ligation methods

  8. Data analysis: Use peak-calling algorithms suited for histone modifications (broad peaks) rather than transcription factors (narrow peaks)

  For CUT&RUN or CUT&Tag alternatives, which offer improved signal-to-noise ratio, the typical antibody dilution is 1:50, similar to protocols established for other histone methylation marks like H3K4me1 .

• How can researchers distinguish between mono-, di-, and tri-methylation effects at histone H3 K80?

  Distinguishing between different methylation states at H3K80 requires a multi-faceted approach:

  1. Antibody specificity validation: Use peptide arrays containing mono-, di-, and tri-methylated H3K80 peptides to confirm antibody specificity

  2. Mass spectrometry analysis: Apply differential top-down mass spectrometry to quantify the relative abundance of each methylation state, similar to approaches used for other histone modifications

  3. Methyltransferase manipulation: Selectively knock down methyltransferases that catalyze specific methylation states (e.g., enzymes that deposit mono- vs. di-/tri-methylation marks)

  4. Demethylase studies: Utilize demethylases that preferentially remove specific methylation states to study their distinct functions

  5. Reader domain identification: Identify proteins with domains that specifically recognize mono-, di-, or tri-methylated lysines, such as chromodomains, tudor domains, or PHD fingers

  In functional genomics studies, researchers often employ methyltransferase-specific inhibitors or utilize genetic models with lysine-to-methionine (K-to-M) mutations that act as dominant-negative inhibitors of specific histone methylation states .

• What are the known cross-talks between H3K80 mono-methylation and other histone modifications?

  Histone modifications frequently exhibit cross-talk, where one modification influences the deposition or removal of another. For H3K80me1, researchers can investigate potential cross-talk using the following approaches:

  1. Sequential ChIP (Re-ChIP): Perform immunoprecipitation first with Mono-Methyl-Histone H3 (K80) Antibody, then with antibodies against other modifications to identify co-occurrence

  2. Proteomic analysis: Use mass spectrometry to identify modification patterns on the same histone tail, as demonstrated in studies of H3K36 methylation and H3K27 methylation antagonism

  3. Enzyme inhibition studies: Inhibit specific histone-modifying enzymes and monitor effects on H3K80 mono-methylation levels

  4. Genetic studies: Analyze the effects of mutations in one histone-modifying enzyme on the levels of H3K80me1

  Research has shown that acetylation and methylation can influence each other, with acetylation often reducing the positive charge on lysine residues, potentially affecting nearby methylation sites . The "trivalent hypermethylation" pattern observed in some studies suggests potential cooperative effects between different methylation sites .

• How do you optimize immunoprecipitation protocols with Mono-Methyl-Histone H3 (K80) Antibody for mass spectrometry analysis?

  For effective mass spectrometry analysis of H3K80me1-associated proteins, optimize the immunoprecipitation (IP) protocol as follows:

  1. Sample preparation:

     • Extract histones using acid extraction as described earlier

     • For protein complex analysis, use gentler nuclear extraction methods with non-ionic detergents

  2. IP conditions:

     • Use approximately 1:25 antibody dilution for immunoprecipitation

     • Pre-clear lysates with protein A/G beads to reduce background

     • Include protease inhibitors, phosphatase inhibitors, and deacetylase inhibitors (e.g., sodium butyrate) to preserve modifications

  3. Washing conditions:

     • Use stringent washing conditions with increasing salt concentrations

     • Include detergent in early washes to reduce non-specific binding

  4. Elution and digestion:

     • Elute with either acidic conditions or competition with excess peptide

     • For protein interactors, on-bead tryptic digestion often yields cleaner results

  5. Mass spectrometry considerations:

     • Use high-resolution mass analyzers (e.g., Orbitrap) with settings similar to those used in published histone modification studies :

       • 60,000 resolution for MS spectra

       • Automatic gain control target of 1e6

       • Maximum ion time of 1000 ms for MS and 50 ms for MS/MS

  This approach can help identify proteins that specifically interact with the H3K80me1 modification, potentially revealing its functional roles in chromatin regulation.

• What experimental approaches can investigate the dynamics of H3K80 mono-methylation during cellular processes?

  To study H3K80me1 dynamics during cellular differentiation or in response to stimuli:

  1. Time-course ChIP-seq:

     • Collect cells at multiple time points during differentiation or after stimulus

     • Perform ChIP-seq with Mono-Methyl-Histone H3 (K80) Antibody

     • Correlate changes in H3K80me1 with gene expression changes

  2. Live-cell imaging:

     • Use antibody-based approaches with fluorescently labeled secondary antibodies

     • For non-invasive monitoring, develop systems using fluorescently tagged reader domains specific for H3K80me1

  3. Single-cell approaches:

     • Apply CUT&Tag or CUT&RUN protocols adapted for single cells to map H3K80me1 during differentiation at the single-cell level

     • Correlate with single-cell RNA-seq to link modifications to transcriptional changes

  4. Perturbation studies:

     • Use TSA (trichostatin A) or other HDAC inhibitors to study interactions between acetylation and H3K80 methylation, similar to approaches used for other histone modifications

     • Apply K-to-M mutation strategies to disrupt specific methylation pathways and observe effects on H3K80me1

  5. Quantitative mass spectrometry:

     • Use SILAC or TMT labeling to quantify changes in H3K80me1 levels in response to stimuli

     • Apply targeted approaches like parallel reaction monitoring for focused analysis

  These approaches can reveal the temporal dynamics and functional significance of H3K80 mono-methylation in various biological contexts.

• How do you interpret contradictory results between different experimental techniques when studying H3K80 mono-methylation?

  When facing contradictory results between techniques like ChIP-seq, immunofluorescence, and Western blotting when studying H3K80me1, consider these analytical approaches:

  1. Antibody validation review:

     • Reassess antibody specificity using peptide arrays and competition assays

     • Consider using multiple antibodies targeting the same modification from different sources

     • Verify antibody lot consistency if contradictions arise after changing lots

  2. Technique-specific considerations:

     • ChIP-seq: Evaluate fixation conditions, sonication efficiency, and peak calling algorithms

     • Immunofluorescence: Review fixation methods, permeabilization protocols, and epitope accessibility

     • Western blotting: Assess extraction methods, transfer efficiency, and blocking conditions

  3. Biological context analysis:

     • Cell cycle effects: Some modifications vary throughout the cell cycle

     • Cell heterogeneity: Bulk analysis may mask cell-type-specific differences

     • Chromatin context: The same modification may have different accessibility in different chromatin states

  4. Integration strategies:

     • Use complementary techniques to validate findings

     • Apply computational approaches to integrate data from multiple platforms

     • Consider the resolution limits of each technique when interpreting results

  5. Control experiments:

     • Perform genetic perturbation of known methyltransferases/demethylases

     • Use spike-in controls for technical normalization across experiments

  Methodologically, when resolving contradictions, prioritize orthogonal validation approaches and consider the inherent limitations of each technique.

• What are the considerations for using Mono-Methyl-Histone H3 (K80) Antibody in analyzing histone modifications in disease models?

  When investigating H3K80me1 in disease models or patient-derived samples, researchers should consider:

  1. Sample preparation optimization:

     • For clinical samples, optimize fixation protocols to preserve histone modifications

     • Consider using fresh frozen tissue rather than formalin-fixed paraffin-embedded (FFPE) samples when possible

     • Develop micro-ChIP protocols for limited clinical material

  2. Normalization strategies:

     • Use spike-in controls with chromatin from another species

     • Normalize to total H3 levels to account for differences in histone content

     • Consider cell-type composition differences when analyzing heterogeneous tissues

  3. Disease-specific considerations:

     • In cancer models, evaluate potential histone H3 mutations (such as K-to-M mutations) that might affect antibody binding

     • In neurodegenerative disorders, consider post-translational modifications that might interfere with detection

     • In inflammatory conditions, account for potential changes in chromatin accessibility

  4. Experimental design for disease studies:

     • Include matched controls from the same tissue/cell type

     • Consider age, sex, and treatment history as potential confounding variables

     • Design time-course studies to capture dynamic changes during disease progression

  5. Data interpretation in disease context:

     • Correlate H3K80me1 changes with transcriptional alterations in disease states

     • Analyze pathway enrichment for genes associated with differential H3K80me1

     • Compare patterns with other epigenetic modifications to identify disease-specific signatures

  These considerations help ensure robust and reproducible results when studying H3K80 mono-methylation in disease contexts, potentially revealing novel therapeutic targets or biomarkers.